Lastest Stories by Liam

Investors looking to start the new year with some added well-being in their portfolio have a built-for-purpose fund to consider.    A new mental health-focused exchange-traded fund (ETF) has...
Alchemy Investments, a special purpose acquisition company (SPAC) with a “focus on data analytics,” is preparing to raise $100 million through its impending initial public offering. 
For investors looking for more exposure to Israeli startups, a built-for-purpose initial public offering has arrived on the scene.
The owner of the Fogo de Chão chain of Brazilian-themed restaurants has filed for an IPO, the second time the company will have been publicly traded since 2016. If the IPO is completed, of course.
Acrivon Therapeutics aims to raise $100M through its initial public offering in what is shaping up to be one of the largest biotech IPOs for the year.